Suppr超能文献

急性非淋巴细胞白血病患者中博来霉素反应性铁

Bleomycin-reactive iron in patients with acute non-lymphocytic leukemia.

作者信息

Gordeuk V R, Brittenham G M

机构信息

Department of Medicine, MetroHealth Medical Center, Cleveland, OH 44109.

出版信息

FEBS Lett. 1992 Aug 10;308(1):4-6. doi: 10.1016/0014-5793(92)81037-m.

Abstract

Bleomycin-reactive iron was detected in the sera of six out of nine adults undergoing intensive chemotherapy for acute non-lymphocytic leukemia. In these individuals the corresponding transferrin saturation ranged from 96% to 113% and the serum ferritin from 775 to 9975 micrograms/l. Nontransferrin-bound iron has been postulated to be a factor in organ toxicity in iron overload conditions such as beta thalassemia and hereditary hemochromatosis by facilitating the production of tissue-damaging free radicals. We propose that bleomycin-reactive iron should be considered as a possible factor in organ dysfunction seen with intensive cancer chemotherapy.

摘要

在9名接受急性非淋巴细胞白血病强化化疗的成年人中,有6人的血清中检测到了博来霉素反应性铁。在这些个体中,相应的转铁蛋白饱和度为96%至113%,血清铁蛋白为775至9975微克/升。在诸如β地中海贫血和遗传性血色素沉着症等铁过载情况下,非转铁蛋白结合铁被认为是器官毒性的一个因素,因为它会促进产生组织损伤性自由基。我们认为,博来霉素反应性铁应被视为强化癌症化疗中出现器官功能障碍的一个可能因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验